| Date | Time | Source | Headline | Symbol | Company |
| 01/05/2005 | 9:30AM | PR Newswire (US) | Neurobiological Technologies, Inc. Appoints Director of Regulatory Affairs | NASDAQ:NTII | Neurobiological Technologies (MM) |
| 12/13/2004 | 9:15AM | PR Newswire (US) | Neurobiological Technologies, Inc. Reports H. Lundbeck's Ebixa(r) Has Health Canada Approval to Treat Moderate-to-Severe Alzheim | NASDAQ:NTII | Neurobiological Technologies (MM) |
| 11/24/2004 | 9:00AM | PR Newswire (US) | Neurobiological Technologies, Inc. to Present at the Wall Street Analyst Forum On December 1, 2004 | NASDAQ:NTII | Neurobiological Technologies (MM) |
| 11/19/2004 | 11:56AM | PR Newswire (US) | Neurobiological Technologies, Inc. Announces Election of Dr. Ronald E. Cape to Board of Directors | NASDAQ:NTII | Neurobiological Technologies (MM) |
| 11/18/2004 | 1:00PM | PR Newswire (US) | Neurobiological Technologies, Inc. Appoints Vice President and CFO | NASDAQ:NTII | Neurobiological Technologies (MM) |
| 11/15/2004 | 6:14PM | PR Newswire (US) | Neurobiological Technologies, Inc. Reports FDA Has Accepted Forest Lab's sNDA Filing to Expand Namenda's Indication to Include M | NASDAQ:NTII | Neurobiological Technologies (MM) |
| 11/09/2004 | 8:30AM | PR Newswire (US) | Scimitar Equity Research Issues Review of Neurobiological Technologies, Inc. | NASDAQ:NTII | Neurobiological Technologies (MM) |
| 11/08/2004 | 9:01AM | PR Newswire (US) | Neurobiological Technologies, Inc. Reports First Quarter Results | NASDAQ:NTII | Neurobiological Technologies (MM) |
| 11/04/2004 | 9:00AM | PR Newswire (US) | Neurobiological Technologies, Inc. Receives $694,000 Royalty Payment for Anti-Alzheimer Product | NASDAQ:NTII | Neurobiological Technologies (MM) |
| 11/02/2004 | 10:30AM | PR Newswire (US) | Neurobiological Technologies to Report First Quarter Financial Results and Host Conference Call on November 8, 2004 | NASDAQ:NTII | Neurobiological Technologies (MM) |
| 10/20/2004 | 2:59PM | PR Newswire (US) | Neurobiological Technologies, Inc. to Present at The Rodman & Renshaw Techvest 6th Annual Healthcare Conference on October 27, 2 | NASDAQ:NTII | Neurobiological Technologies (MM) |
| 08/23/2004 | 9:45AM | PR Newswire (US) | Neurobiological Technologies Names David E. Levy, M.D., As Vice President of Clinical Development to Lead Viprinex(TM) Team | NASDAQ:NTII | Neurobiological Technologies (MM) |
| 08/20/2004 | 9:30AM | PR Newswire (US) | Scimitar Equity Research Issues Review of Neurobiological Technologies, Inc. | NASDAQ:NTII | |
| 08/19/2004 | 9:30AM | PR Newswire (US) | Neurobiological Technologies Reports Fourth Quarter and Fiscal 2004 Financial Results | NASDAQ:NTII | Neurobiological Technologies (MM) |
| 08/16/2004 | 9:30AM | PR Newswire (US) | Neurobiological Technologies to Report Fourth Quarter and Fiscal Year Financial Results and Host Conference Call on August 19, 2 | NASDAQ:NTII | Neurobiological Technologies (MM) |
| 07/15/2004 | 8:30AM | PR Newswire (US) | Neurobiological Technologies Acquires Empire Pharmaceuticals, Further Expanding Pipeline With Late-Stage Stroke Compound Viprine | NASDAQ:NTII | Neurobiological Technologies (MM) |
| 05/12/2004 | 10:01AM | PR Newswire (US) | Neurobiological Technologies Provides Company Update to J.M. Dutton Research Team | NASDAQ:NTII | Neurobiological Technologies (MM) |
| 05/10/2004 | 9:30AM | PR Newswire (US) | Neurobiological Technologies, Inc. Reports Third Quarter Results | NASDAQ:NTII | Neurobiological Technologies (MM) |
| 05/03/2004 | 10:00AM | PR Newswire (US) | Neurobiological Technologies, Inc. To Report Fiscal 2004 Third Quarter Financial Results and Host Conference Call on May 10, 200 | NASDAQ:NTII | Neurobiological Technologies (MM) |
| 04/21/2004 | 10:00AM | PR Newswire (US) | Conference Call Alert - Neurobiological Technologies, Inc. (Nasdaq: NTII) | NASDAQ:NTII | |
| 04/20/2004 | 10:00AM | PR Newswire (US) | Neurobiological Technologies Initiates Pivotal Phase III Clinical Trial Program of XERECEPT(TM) For Brain Swelling Associated Wi | NASDAQ:NTII | Neurobiological Technologies (MM) |
| 03/02/2004 | 8:00AM | PR Newswire (US) | Neurobiological Technologies Raises $19.4 Million in Private Equity Financing | NASDAQ:NTII | Neurobiological Technologies (MM) |
| 02/09/2004 | 9:01AM | PR Newswire (US) | Neurobiological Technologies Reports Fiscal 2004 Second Quarter Results | NASDAQ:NTII | Neurobiological Technologies (MM) |
| 12/15/2003 | 8:00AM | PR Newswire (US) | Neurobiological Technologies, Inc. Announces Holding of Investigators Meeting For Phase III Trials for XERECEPT(TM) | NASDAQ:NTII | Neurobiological Technologies (MM) |
| 12/04/2003 | 7:45AM | PR Newswire (US) | NTII Presentation at Redchip Scottsdale Investor Conference 2003 | NASDAQ:NTII | Neurobiological Technologies (MM) |
| 11/12/2003 | 8:30AM | PR Newswire (US) | Neurobiological Technologies, Inc. Reports First Quarter Results | NASDAQ:NTII | Neurobiological Technologies (MM) |
| 11/05/2003 | 9:30AM | PR Newswire (US) | Conference Call Alert - Neurobiological Technologies, Inc. (Nasdaq: NTII) | NASDAQ:NTII | |